BRPI0508927A - compounds useful for treating diseases - Google Patents

compounds useful for treating diseases

Info

Publication number
BRPI0508927A
BRPI0508927A BRPI0508927-1A BRPI0508927A BRPI0508927A BR PI0508927 A BRPI0508927 A BR PI0508927A BR PI0508927 A BRPI0508927 A BR PI0508927A BR PI0508927 A BRPI0508927 A BR PI0508927A
Authority
BR
Brazil
Prior art keywords
compounds useful
treating diseases
compounds
diseases
useful
Prior art date
Application number
BRPI0508927-1A
Other languages
Portuguese (pt)
Inventor
Alan Daniel Brown
Mark Edward Bunnage
Paul Alan Glossop
Kim James
Charlotte Alice Louise Lane
Russell Andrew Lewthwaite
Graham Lunn
David Anthony Price
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290725A external-priority patent/EP1577291A1/en
Priority claimed from GB0425064A external-priority patent/GB0425064D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0508927A publication Critical patent/BRPI0508927A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSTOS úTEIS PARA O TRATAMENTO DE DOENçAS. A invenção diz reseito aos compostos de fórmula (1) e aos processos para a preparação de, intermediários usados na preparação de, composições contendo e usos de, tais derivados. Os compostos de acordo com a presente invenção são úteis em numerosas doenças, distúrbios e condições, em particular doenças, distúrbios e condições inflamatórias, alérgicas e respiratórias.USEFUL COMPOUNDS FOR TREATMENT OF DISEASES. The invention relates to compounds of formula (1) and processes for the preparation of intermediates used in the preparation of compositions containing and uses of such derivatives. The compounds of the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

BRPI0508927-1A 2004-03-17 2005-03-10 compounds useful for treating diseases BRPI0508927A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290725A EP1577291A1 (en) 2004-03-17 2004-03-17 Phenylethanolamine derivatives as beta-2 agonists
US59179004P 2004-07-27 2004-07-27
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases
PCT/IB2005/000640 WO2005090287A2 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists

Publications (1)

Publication Number Publication Date
BRPI0508927A true BRPI0508927A (en) 2007-08-14

Family

ID=56290672

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508927-1A BRPI0508927A (en) 2004-03-17 2005-03-10 compounds useful for treating diseases

Country Status (7)

Country Link
EP (1) EP1727789A2 (en)
JP (1) JP4054366B2 (en)
AU (1) AU2005223488A1 (en)
BR (1) BRPI0508927A (en)
CA (1) CA2559203A1 (en)
EA (1) EA200601510A1 (en)
WO (1) WO2005090287A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425054D0 (en) * 2004-03-23 2004-12-15 Pfizer Ltd Formamide derivatives for the treatment of diseases
UA87854C2 (en) * 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
ES2320961B1 (en) * 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) PHENOL AS BETA2 ADRENERGIC RECEIVER AGONISTS.
PL2231642T3 (en) 2008-01-11 2014-04-30 Novartis Ag Pyrimidines as kinase inhibitors
JP5801997B2 (en) 2009-07-07 2015-10-28 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ Dosing unit, dosing unit pack, and inhaler for inhaling a combination of drugs
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
BR112013021638A2 (en) 2011-02-25 2016-08-02 Irm Llc "trk inhibiting compounds, their use and compositions comprising them"
CN116033893A (en) 2020-06-26 2023-04-28 迈兰制药英国有限公司 Formulations comprising 5- [3- (3-hydroxyphenoxy) azetidin-1-yl ] -5-methyl-2, 2-diphenylhexanamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1529972A (en) * 1975-07-29 1978-10-25 Allen & Hanburys Ltd Basic alcohols
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
KR850007422A (en) * 1984-04-17 1985-12-04 원본미기재 Method for preparing a phenethanolamine compound
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
OA11558A (en) * 1999-12-08 2004-06-03 Advanced Medicine Inc Beta 2-adrenergic receptor agonists.
WO2003042160A1 (en) * 2001-11-13 2003-05-22 Theravance, Inc. Aryl aniline beta-2 adrenergic receptor agonists
AU2003222841A1 (en) * 2002-04-25 2003-11-10 Glaxo Group Limited Phenethanolamine derivatives
EP1477167A1 (en) * 2003-05-15 2004-11-17 Pfizer Limited [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists

Also Published As

Publication number Publication date
EP1727789A2 (en) 2006-12-06
WO2005090287A3 (en) 2006-02-16
WO2005090287A2 (en) 2005-09-29
JP4054366B2 (en) 2008-02-27
JP2007529501A (en) 2007-10-25
CA2559203A1 (en) 2005-09-29
AU2005223488A1 (en) 2005-09-29
EA200601510A1 (en) 2007-04-27

Similar Documents

Publication Publication Date Title
BRPI0507041A (en) sulfonamide-derived compounds for the treatment of diseases their uses, process for the preparation of compounds and combination of compounds
BRPI0408369A (en) indole derivatives useful for treating disease
BRPI0508927A (en) compounds useful for treating diseases
BR0307564A (en) Nicotinamide derivatives useful as pde4 inhibitors
BRPI0507085A (en) sulfonamide derivatives, pharmaceutical composition, uses, processes for preparation and combination
CR8649A (en) FORMAMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
ATE432278T1 (en) COMPOUNDS FOR TREATING DISEASES
BRPI0410660A (en) 2-amino-pyridine derivatives as ß2 adrenoreceptor agonists
EA200870282A1 (en) AMINE DERIVATIVES
ECSP056164A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
UY28339A1 (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
BRPI0509667B8 (en) compound, process for the preparation of a compound of formula (I), medicine and use of a compound
ATE440836T1 (en) LINKS
BRPI0509137A (en) compounds for the treatment of diseases
UY28819A1 (en) FORMAMIDA DERIVATIVES FOR THE TREATMENT OF DISEASES
PE20030337A1 (en) INDAN-1-ONAS SUBSTITUTED IN C2 AND ITS DERIVATIVES, PROCEDURE FOR ITS PREPARATION AND ITS USE AS MEDICINES
DOP2005000043A (en) COMPOUNDS FOR THE TREATMENT OF DISEASES
DOP2005000037A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
UY28810A1 (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
UY28816A1 (en) COMPOUNDS FOR THE TREATMENT OF DISEASES
DOP2004000902A (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
DOP2004000921A (en) USED 2-AMINO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES
CU23661B7 (en) FORMAMIDA DERIVATIVES FOR THE TREATMENT OF DISEASES
DOP2005000041A (en) COMPOUNDS FOR THE TREATMENTS OF DISEASES

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired